Piper Therapeutics' Incubator/Accelerator Round

Piper Therapeutics raised a round of funding on December 21, 2016. Investors include Harvard Life Lab.

Piper Therapeutics is focused on higher order pathways that govern immune and inflammatory response. The company is developing therapies to promote a microenvironment to inhibit tumor growth, slow sep…

Articles about Piper Therapeutics' Incubator/Accelerator Round: